📰 Pharmaceutical Compounding News
Pharmaceutical Compounding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmaceutical Compounding. Real-time updates on events, politics, business and more.
August 28, 2023
Lots of people turn to these drug-free herbal remedies for a better night’s rest. Learn about some of the most popular natural sleep treatments and whether they work.
June 28, 2023
HROW | Complete Harrow Health Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
February 20, 2023
Pharmaceutical compounding is when your local pharmacist creates custom medications. The combined ingredients can be made up in the exact strength and dosage required by a patient according to their unique needs.Compound
November 10, 2022
USP presented to NCPA’s Compounding Committee on its revised compounding chapters (Pharmaceutical Compounding – Sterile Preparations) and (Pharmaceutical Compounding – Sterile Preparations). Click here for more information on the revisions. USP published updates to these chapters in the USP-NF and USP Compounding Compendium on Nov. 1.
October 12, 2022
USP announced that it will publish updates to General Chapters (Pharmaceutical Compounding – Sterile Preparations) and (Pharmaceutical Compounding — Sterile Preparations) in the USP-NF and USP Compounding Compendium on Nov. 1, 2022.
September 20, 2022
A beta blocker eye drop that costs less than $10 may be able to help acute migraine sufferers ...
April 7, 2022
Russell Investments Group Ltd. bought a new stake in Harrow Health, Inc. (NASDAQ:HROW – Get Rating) during the 4th quarter, Holdings Channel reports. The fund bought 285,436 shares of the company’s stock, valued at approximately $2,464,000. Other hedge funds and other institutional investors have also modified their holdings of the company. Opaleye Management Inc. boosted […]
March 11, 2022
Harrow Health (NASDAQ:HROW – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.35), MarketWatch Earnings reports. Harrow Health had a negative net margin of 14.11% and a positive return on equity of 13.06%. During the same period last year, […]
January 11, 2022
Hamad Medical Corporation (HMC) s National Centre for Cancer Care and Research (NCCCR) is planning to introduce a range of innovative services to trea...
October 12, 2021
The Ohio Northern University Raabe College of Pharmacy student will share his vision of “The Compounding Pharmacy of the Future” at the compounding...